Table 1.
Primers used for PCR.
Primers used for generation of pcDNA5/FRTpuro vector | |||
---|---|---|---|
Fragment | Primer | Sequene (5′–3′) | Amplicon size (bp) |
pcDNA5 backbone | PuroR_p5_fwd | cacgaccccatgGGCTGGATGATCCTCCAGCG | 3,834 |
SV40/FRT_p5_rev | gacacgtacgtacgtGGCGAACGTGGCGAGAAAGG | ||
Puromycin resistance | SV40/FRT_PuroR_fwd | ttccttggccACCGAGTACAAGCCCACGG | 669 |
p5_PuroR_rev | tcatccagccCATGGGGTCGTGCGCTCC | ||
SV40 promotor-FRT region | p5_SV40/FRT_fwd | gccacgtacgtacgtGTCAGTTAGGGTGTGGAAAG | 395 |
PuroR_SV40/FRT_rev | tcggtggccaagGAAGTTCCTATACTTTCTAGAG |
Primers used for site-directed mutagenesis | |||
---|---|---|---|
Vector | Primer | Sequence (5′–3′) | Amplicon size (bp) |
pcDNA5/FRThygro | SDM_hygro_fwd | GTATAGGAACTTCCTTGGC-AAAAAGCCTGAACTCACC | N/A |
SDM_hygro_rev | GGTGAGTTCAGGCTTTTT-GCCAAGGAAGTTCCTATAC | ||
pcDNA5/FRTpuro | SDM_puro_fwd | CATGGCAGAAGTTCCTATTCCGAAGTTCC | N/A |
SDM_puro_rev | AATAGGAACTTCTGCCATGGTAGCCTCC |
Primers used for cloning of CYP2C19 | |||
---|---|---|---|
Reaction | Primer | Sequence (5′–3′) | Amplicon size (bp) |
Reverse transcription | CYP2C19_GSP_rev | GAGGAAAGAGAGCTGCAGGG | N/A |
Introduction of restriction sites | CYP2C19_HindIII_fwd | AAGAGGAGaagcttACCATGGATCCTTTTGTGGTCCTTG | 1516 |
CYP2C19_EcoRV_rev | CATCTGTgatatcTCAGACAGGAATGAAGCACAGC |
Primers used for Validation PCRs | |||
---|---|---|---|
Reaction | Primer | Sequence (5′–3′) | Amplicon size (bp) |
Integration PCR 1 | PSV40 | AGCTGTGGAATGTGTGTCAGTTAGG | 559 |
Ppuro_r | CGACGCGCGTGAGGAAGAGTTCTTG | ||
Integration PCR 2 | Puni_f | CGTTCGCCACGTACGTACGTGTCAG | 489 |
Phyr_r | CTTCGCCCTCCGAGAGCTGCATCAG | ||
Multiple Integration PCR A | Puni_f | CGTTCGCCACGTACGTACGTGTCAG | 564 |
Ppuro_r | CGACGCGCGTGAGGAAGAGTTCTTG | ||
Multiple Integration PCR B | PFRT_f | AATCGGGGGCTCCCTTTAGGGTTCC | 313 |
Ppuro_r | CGACGCGCGTGAGGAAGAGTTCTTG | ||
Multiple Integration PCR C | PFRT_f | AATCGGGGGCTCCCTTTAGGGTTCC | 238 |
Phyr_r | CTTCGCCCTCCGAGAGCTGCATCAG |
Primers used for quantitative RT-PCR | |||
---|---|---|---|
Gene | Primer | Sequence (5′-3′) | Amplicon size (bp) |
CYP2C19 | PCYP2C19_f | CCTGATCAAAATGGAGAAGGAAAAG | 99 |
PCYP2C19_r | TCTGTCCCAGCTCCAAGTAAG | ||
HPRT1 | PHPRT1_f | TGACACTGGCAAAACAATGCA | 94 |
PHPRT1_r | GGTCCTTTTCACCAGCAAGCT | ||
OCT1 | POCT1_f | TGTCACCGAAAAGCTGAGCC | 96 |
POCT1_r | TCCGTGAACCACAGGTACATC |
The 5′-hybrid part of primers used for generation of overlapping amplicons for creation of the pcDNA5/FRTpuro vector is shown by nucleotides in small capital letters. The unique sequence introduced into the generated vector is underscored. The newly introduced base into the pcDNA5/FRTpuro vector for frame shift generation is marked in bold, the nucleotide substitution for the correction of the FRT site is highlighted by an italic, bold letter. The position of the single nucleotide deletion introduced into the pcDNA5/FRThygro vector is shown by a hyphen. Endonuclease restriction sites are indicated by lower case letters.